which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. For therapeutic cancer vaccination, the adoptive transfer of mRNA-electroporated dendritic cells (DCs) is frequently performed, usually with monocyte-derived, cytokine-matured DCs (moDCs). However, DCs are rich in danger-sensing receptors which could recognize the exogenously delivered mRNA and induce DC activation, hence influencing the DCs ’ immunogenicity. Therefore, we examined whether electroporation of mRNA with a proper cap and a poly-A tail of at least 64 adenosines had any influenc
AbstractThe manipulation of dendritic cells (DCs) ex vivo to present tumor-associated antigens for t...
Tumor cells that show downregulation of their tumor-associated antigens (TAAs) may be able to escape...
The manipulation of dendritic cells (DCs) ex vivo to present tumor-associated antigens for the activ...
Contains fulltext : 79503.pdf (publisher's version ) (Closed access)Tumor-derived ...
Contains fulltext : 80296.pdf (publisher's version ) (Closed access)Electroporatio...
A critical factor determining the effectiveness of currently used dendritic cell (DC)-based vaccines...
In the last few decades, immunotherapy has emerged as an alternative therapeutic approach to treat c...
Recently, human dendritic cells (DCs) pulsed with mRNA encoding a broad range of tumor antigens have...
Dendritic cells (DC) are unique antigen-presenting cells that initiate and orchestrate adaptive immu...
The use of tumor antigen-loaded dendritic cells (DC) is one of the most promising approaches to indu...
The use of tumor antigen-loaded dendritic cells (DC) is one of the most promising approaches to indu...
We previously described mRNA electroporation as an efficient gene delivery method to introduce tumor...
Until now, studies utilizing mRNA electroporation as a tool for the delivery of tumor antigens to hu...
The immune system is a crucial player in the development of cancer. Once it is in imbalance and immu...
PURPOSE: A critical factor determining the effectiveness of currently used dendritic cell (DC)-based...
AbstractThe manipulation of dendritic cells (DCs) ex vivo to present tumor-associated antigens for t...
Tumor cells that show downregulation of their tumor-associated antigens (TAAs) may be able to escape...
The manipulation of dendritic cells (DCs) ex vivo to present tumor-associated antigens for the activ...
Contains fulltext : 79503.pdf (publisher's version ) (Closed access)Tumor-derived ...
Contains fulltext : 80296.pdf (publisher's version ) (Closed access)Electroporatio...
A critical factor determining the effectiveness of currently used dendritic cell (DC)-based vaccines...
In the last few decades, immunotherapy has emerged as an alternative therapeutic approach to treat c...
Recently, human dendritic cells (DCs) pulsed with mRNA encoding a broad range of tumor antigens have...
Dendritic cells (DC) are unique antigen-presenting cells that initiate and orchestrate adaptive immu...
The use of tumor antigen-loaded dendritic cells (DC) is one of the most promising approaches to indu...
The use of tumor antigen-loaded dendritic cells (DC) is one of the most promising approaches to indu...
We previously described mRNA electroporation as an efficient gene delivery method to introduce tumor...
Until now, studies utilizing mRNA electroporation as a tool for the delivery of tumor antigens to hu...
The immune system is a crucial player in the development of cancer. Once it is in imbalance and immu...
PURPOSE: A critical factor determining the effectiveness of currently used dendritic cell (DC)-based...
AbstractThe manipulation of dendritic cells (DCs) ex vivo to present tumor-associated antigens for t...
Tumor cells that show downregulation of their tumor-associated antigens (TAAs) may be able to escape...
The manipulation of dendritic cells (DCs) ex vivo to present tumor-associated antigens for the activ...